Skip to main content

Articles

Page 3 of 74

  1. To evaluate the impact of prophylactic cranial irradiation (PCI) on the prognosis of patients with limited-stage small cell lung cancer (SCLC) in the era of MRI surveillance.

    Authors: Mengyuan Chen, Zehua Sun, Jingcong Pan, Yujin Xu, Yuezhen Wang, Ming Chen and Xiao Hu
    Citation: Radiation Oncology 2024 19:162
  2. Craniopharyngioma is a rare and slow-growing benign sellar or parasellar epithelial tumor. The number of patients receiving proton beam therapy (PBT) has increased. This study aimed to systematically evaluate ...

    Authors: Zhi Li, Qingyong Li, Haidong Tian, Maoqing Wang, Ru Lin, Juan Bai, Dandan Wang and Meng Dong
    Citation: Radiation Oncology 2024 19:161
  3. Intrahepatic cholangiocarcinoma (ICC) is a challenging primary liver cancer with a poor prognosis, especially in unresectable cases. Traditional palliative irradiation is limited in reducing liver doses. This ...

    Authors: Akihito Okubo, Sae Matsumoto, Hiroyasu Tamamura, Yoshitaka Sato, Satoko Asahi, Hitoshi Tatebe, Kazutaka Yamamoto, Keiichiro Matsushita, Makoto Sasaki, Yoshikazu Maeda, Yuji Tameshige, Hajime Sunagozaka, Hiroyuki Aoyagi, Satoshi Shibata, Shigeyuki Takamatsu and Satoshi Kobayashi
    Citation: Radiation Oncology 2024 19:160
  4. Pulsed low dose rate radiotherapy (PLDR) is a new radiation delivery method, in which the fractional dose is divided into sub-fractional doses with periodical time breaks in between. The goal of our study is t...

    Authors: Noha Roshdy Salem, Ahmed Eldib, E. M. El-Sayed, Ehab Mostafa and Omar S. Desouky
    Citation: Radiation Oncology 2024 19:159
  5. The aim of this study was to evaluate the inter-fraction reproducibility and intra-fraction stability of breast radiotherapy using voluntary deep-inspiration breath hold (DIBH) and free breathing (FB) based on...

    Authors: Junxiang Wu, Feng Yang, Jie Li, Xianliang Wang, Ke Yuan, Lipeng Xu, Fan Wu, Bin Tang and Lucia Clara Orlandini
    Citation: Radiation Oncology 2024 19:158
  6. Recent research has demonstrated that the use of artificial intelligence (AI) in radiotherapy (RT) has significantly streamlined the process for physicians to treat patients with tumors; however, bibliometric ...

    Authors: Minghe Lv, Yue feng, Su Zeng, Yang Zhang, Wenhao Shen, Wenhui Guan, Xiangyu E., Hongwei Zeng, Ruping Zhao and Jingping Yu
    Citation: Radiation Oncology 2024 19:157
  7. Durvalumab, an anti-PD-L1 immune checkpoint inhibitor, after radio-chemotherapy (RCT) has changed the management of locally advanced non-small cell lung cancer (LA NSCLC). A series of retrospective studies hav...

    Authors: Arnaud Colomb, Benoit Allignet, Mehdi Lamkhioued, Aurelie Swalduz, Lionel Falchero, Aurélie Kienlen, Michaël Duruisseaux and Coralie Moncharmont
    Citation: Radiation Oncology 2024 19:156
  8. Growth differentiation factor 15 (GDF15) is a cytokine of the TGFβ family. Here, we analyzed GDF15 levels in patients with locally advanced non-small cell lung cancer (LA-NSCLC) who participated in OCOG-ALMERA...

    Authors: Fiorella Di Pastena, Gregory Pond, Evangelia E. Tsakiridis, Andre Gouveia, Elham Ahmadi, Olga-Demetra Biziotis, Amr Ali, Anand Swaminath, Gordon Okawara, Peter M. Ellis, Bassam Abdulkarim, Naseer Ahmed, Andrew Robinson, Wilson Roa, Mario Valdes, Peter Kavsak…
    Citation: Radiation Oncology 2024 19:155
  9. Tyrosine Kinase Inhibitors (TKIs) is an important therapy for patients with oncogene-mutated Non-Small Cell Lung Cancer (NSCLC). However, acquired resistance remains a major challenge. The efficacy of TKIs plu...

    Authors: Wenxia Li, Peiye Wu, Zhanpeng Liang, Luzhen Li, Yunqi Chen, Wenjing Zhang, Huatang Zhang and Cantu Fang
    Citation: Radiation Oncology 2024 19:154
  10. In locally advanced rectal cancer, the prediction of tumor response during and after neoadjuvant treatment remains challenging. In terms of organ preservation, adaptive radiotherapy, and intensified (total) ne...

    Authors: Kerstin Clasen, Cihan Gani, Leon Schuetz, Stephan Clasen, Nadja Ballin, Irina Bonzheim, Michael Orth, Stephan Ossowski, Olaf Riess, Maximilian Niyazi, Christopher Schroeder and Olga Kelemen
    Citation: Radiation Oncology 2024 19:153
  11. This study aims to evaluate the efficacy and safety of 3D printing technology in brachytherapy for cervical cancer, comparing its outcomes with conventional free hand implantation brachytherapy.

    Authors: Zenghong Lu, Gangfeng Zhu, Zhengang Qiu, Hailiang Guo, Junyan Li, Liangjian Zheng, Cixiang Chen, Jie Che, Yi Xiang and Yili Wang
    Citation: Radiation Oncology 2024 19:152
  12. Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival. In the context of bone metastases radiotherapy, low rates...

    Authors: Carsten Nieder, Ellinor C. Haukland, Luka Stanisavljevic and Bård Mannsåker
    Citation: Radiation Oncology 2024 19:151
  13. Head and neck squamous cell carcinoma (HNSCC) negative for Human Papillomavirus (HPV) has remained a difficult to treat entity, whereas tumors positive for HPV are characterized by radiosensitivity and favorab...

    Authors: Henrike Barbara Zech, Clara von Bargen, Agnes Oetting, Nikolaus Möckelmann, Christina Möller-Koop, Melanie Witt, Nina Struve, Cordula Petersen, Christian Betz, Kai Rothkamm, Adrian Münscher, Till Sebastian Clauditz and Thorsten Rieckmann
    Citation: Radiation Oncology 2024 19:150
  14. Magnetic resonance imaging is indispensable for the preoperative diagnosis of glioma. This study aimed to investigate the role of the apparent diffusion coefficient values as predictors of survival in patients...

    Authors: Xue Jiang, Xu-Ni Xu, Xiao-Ye Yuan, Hao-Ran Jiang, Meng-Jing Zhao, Yu-Xia Duan and Gang Li
    Citation: Radiation Oncology 2024 19:149
  15. Increasing evidence suggests that a subgroup of patients with oligometastatic cancer might achieve a prolonged disease-free survival through local therapy for all active cancer lesions. Our aims are to investi...

    Authors: Sebastian M. Christ, Gabriel W. Thiel, Philip Heesen, Siyer Roohani, Michael Mayinger, Jonas Willmann, Maiwand Ahmadsei, Urs J. Muehlematter, Alexander Maurer, Josef A. Buchner, Jan C. Peeken, Rifaquat Rahman, Ayal Aizer, Emilie Le Rhun, Nicolaus Andratschke, Michael Weller…
    Citation: Radiation Oncology 2024 19:148
  16. Recurrent and locally advanced gynecological malignancies have a poor prognosis. In particularly, pelvic local recurrence after previous radiotherapy and/or positive resection margins during surgical treatment...

    Authors: Tanja Sprave, Raluca Stoian, Natalia Volegova-Neher, Mark Gainey, Michael Kollefrath, Dimos Baltas, Anca-Ligia Grosu, Ingolf Juhasz-Böss, Rieke Schröder and Florin-Andrei Taran
    Citation: Radiation Oncology 2024 19:147
  17. This study aims to assess the clinical efficacy of elective neck irradiation (ENI) in patients with esthesineuroblastoma (ENB), a rare malignant neoplasm, who are clinically node-negative.

    Authors: Yang Zhao, Li Yan, Ruichen Li, Xiaoshen Wang and Yi Zhu
    Citation: Radiation Oncology 2024 19:146
  18. Using dose-painted intensity-modulated radiation therapy, specific dose volume constraints or implantation of tissue expanders prior to radiotherapy are validated options for reducing radiation dose on the bow...

    Authors: L. Hoeng, A. K. Exeli, G. A. Krombach, T. Schwandner, L. Agolli and D. Habermehl
    Citation: Radiation Oncology 2024 19:145
  19. To investigate the impact of using contrast-enhanced computed tomography (CHCT) in the dosimetry of stereotactic body radiation therapy (SBRT) for liver metastases treated with MR-Linac.

    Authors: Min Liu, Mingzhe Liu, Feng Yang, Yanhua Liu, Shoulong Wang, Yazhen Chen, Jie Li, Xianliang Wang and Lucia Clara Orlandini
    Citation: Radiation Oncology 2024 19:144
  20. The purpose of this study was to investigate the survival benefit of Stereotactic Body Radiotherapy (SBRT) versus lenvatinib as first-line therapy in the treatment of hepatocellular carcinoma (HCC) with portal...

    Authors: Xiaoquan ji, Aimin Zhang, Xuezhang Duan and Quan Wang
    Citation: Radiation Oncology 2024 19:143
  21. Merkel cell carcinoma (MCC) radiation treatment has historically consisted of standard 1.8–2 Gy fractions treated daily over 4–6 weeks. Hypofractionated treatment regimens have demonstrated tumor control and t...

    Authors: Lorein Gonzalez, Muni Rubens, Sreenija Yarlagadda, Guilherme Rabinowits and Noah S. Kalman
    Citation: Radiation Oncology 2024 19:142
  22. The advancement of precision radiotherapy techniques, such as volumetric modulated arc therapy (VMAT), stereotactic body radiotherapy (SBRT), and particle therapy, highlights the importance of radiotherapy in ...

    Authors: Xiangbin Zhang, Di Yan, Haonan Xiao and Renming Zhong
    Citation: Radiation Oncology 2024 19:140
  23. This observational study aims to establish the feasibility of using x-ray images of radio-opaque chemoembolisation deposits in patients as a method for real-time image-guided radiation therapy of hepatocellula...

    Authors: Natalie Plant, Adam Mylonas, Chandrima Sengupta, Doan Trang Nguyen, Shona Silvester, David Pryor, Peter Greer, Yoo Young (Dominique) Lee, Prabhakar Ramachandran, Venkatakrishnan Seshadri, Yuvnik Trada, Richard Khor, Tim Wang, Nicholas Hardcastle and Paul Keall
    Citation: Radiation Oncology 2024 19:139
  24. The aim was to study the potential for an online fully automated daily adaptive radiotherapy (RT) workflow for bladder cancer, employing a focal boost and fiducial markers. The study focused on comparing the g...

    Authors: Sana Azzarouali, Karin Goudschaal, Jorrit Visser, Laurien Daniëls, Arjan Bel and Duncan den Boer
    Citation: Radiation Oncology 2024 19:138
  25. Definitive concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced, inoperable non-small cell lung cancer (NSCLC). Previous studies have mainly focused on examining local failure and...

    Authors: Feifan Sun, Zhiming Chen, Daijun Zhou, Zhihui Li, Haoyang Wang, Rong Zhao, Jing Xian, Jingjing Peng, Xingchen Peng, Chaoyang Jiang, Mei Shi and Dong Li
    Citation: Radiation Oncology 2024 19:137
  26. This report details the experience of a patient who developed a second primary glioblastoma (GB), offering insights into the treatment process and reviewing relevant literature.

    Authors: Bai Jiwei, Muyasha Abulimiti, Jin Yonglong, Wang Jie, Zhang Shuyan, Liu Chao, Wang Zishen, Wang Wei, Li Yinuo, Wang Weiwei, Yang Lu and Shosei Shimizu
    Citation: Radiation Oncology 2024 19:136
  27. Anaplastic meningiomas, categorized as WHO grade 3 tumors, are rare and highly aggressive, accounting for 1-2% of all meningioma cases. Despite aggressive treatment, including surgery and Radiation, they exhib...

    Authors: Ory Haisraely, Alicia Taliansky, Maayan Sivan and Yaacov Lawerence
    Citation: Radiation Oncology 2024 19:135
  28. We conducted a systematic review and meta-analysis to assess the risk of respiratory adverse effects in patients with solid tumors treated with immune checkpoint inhibitors (PD-1, PD-L1 and CTLA-4 inhibitors) ...

    Authors: Zhongjun Ma, Jiexuan Hu, Fei Wu, Naijia Liu and Qiang Su
    Citation: Radiation Oncology 2024 19:134
  29. The 3-variable number-of-risk-factors (NRF) model is a prognostic tool for patients undergoing palliative radiotherapy (PRT). However, there is little research on the NRF model for patients with painful non-bo...

    Authors: Takayuki Sakurai, Tetsuo Saito, Kohsei Yamaguchi, Shigeyuki Takamatsu, Satoshi Kobayashi, Naoki Nakamura and Natsuo Oya
    Citation: Radiation Oncology 2024 19:133
  30. This study aimed to use propensity score matching (PSM) to explore the long-term outcomes and failure patterns in locally advanced rectal cancer (LARC) patients with positive versus negative lateral pelvic lym...

    Authors: Shuai Li, Maxiaowei Song, Jian Tie, Xianggao Zhu, Yangzi Zhang, Hongzhi Wang, Jianhao Geng, Zhiyan Liu, Xin Sui, Huajing Teng, Yong Cai, Yongheng Li and Weihu Wang
    Citation: Radiation Oncology 2024 19:132
  31. This study aims to delineate the long-term outcomes and recurrence patterns of locally advanced thoracic esophageal squamous cell carcinoma (TESCC) patients managed with or without postoperative radiotherapy (...

    Authors: Ya Zeng, Xi Su, Tongfang Zhou, Jingyi Jia, Jun Liu, Wen Yu, Qin Zhang, Xinyun Song, Xiaolong Fu and Xuwei Cai
    Citation: Radiation Oncology 2024 19:130
  32. To evaluate the impact of the residual setup errors from differently shaped region of interest (ROI) and investigate if surface-guided setup can be used in radiotherapy with concurrent tumor treating fields (T...

    Authors: Jiajun Zheng, Geng Xu, Wenjie Guo, Yuanyuan Wang, Jianfeng Wu, Dan Zong, Boyang Ding, Li Sun and Xia He
    Citation: Radiation Oncology 2024 19:129
  33. The stiffness of the tumor microenvironment (TME) directly influences cellular behaviors. Radiotherapy (RT) is a common treatment for solid tumors, but the TME can impact its efficacy. In the case of liver can...

    Authors: Shao-Lun Lu, Yu Pei, Wei-Wen Liu, Kun Han, Jason Chia-Hsien Cheng and Pai-Chi Li
    Citation: Radiation Oncology 2024 19:128
  34. Recent papers suggested a correlation between the risk of distant metastasis (DM) and dose outside the PTV, though conclusions in different publications conflicted. This study resolves these conflicts and prov...

    Authors: D. Dudas, T. J. Dilling and I. El Naqa
    Citation: Radiation Oncology 2024 19:127
  35. Cervical and upper thoracic esophageal cancer (ESCA) presents treatment challenges due to limited clinical evidence. This multi-center study (ChC&UES) explores radical radio(chemo)therapy efficacy and safety, ...

    Authors: Xiao-Han Zhao, Wen-Cheng Zhang, Xin Wang, Jun-Qiang Chen, Yuan-Ji Xu, Kuai-Le Zhao, Wei Huang, Pu-Dong Qian, Ya-Tian Liu, Xiao-Lin Ge, Xiao-Jie Xia, Chen-Gang Weng, Chun-Yue Gai, He-Song Wang, Hong-Mei Gao, Wen-Bin Shen…
    Citation: Radiation Oncology 2024 19:126
  36. To investigate the prognosis of longitudinal health-related quality of life (HRQOL) during concurrent chemoradiotherapy (CCRT) on survival outcomes in patients with advanced nasopharyngeal carcinoma (NPC).

    Authors: Ji-Bin Li, Shan-Shan Guo, Ting Liu, Zhuo-Chen Lin, Wei-Jie Gong, Lin-Quan Tang, Ling Guo, Hao-Yuan Mo, Hai-Qiang Mai and Qiu-Yan Chen
    Citation: Radiation Oncology 2024 19:125
  37. Biology-guided radiotherapy (BgRT) is a novel radiation delivery approach utilizing fluorodeoxyglucose (FDG) activity on positron emission tomography (PET) imaging performed in real-time to track and direct RT...

    Authors: Brittney Chau, Tariq Abuali, Shervin M. Shirvani, David Leung, Karine A. Al Feghali, Susanta Hui, Heather McGee, Chunhui Han, An Liu and Arya Amini
    Citation: Radiation Oncology 2024 19:124
  38. Accelerated partial breast irradiation (APBI) is an accepted treatment option for early breast cancer. Treatment delivered on the Magnetic Resonance integrated Linear Accelerator (MRL) provides the added assur...

    Authors: Jenna Dean, Nigel Anderson, Georgia K. B. Halkett, Jessica Lye, Mark Tacey, Farshad Foroudi, Michael Chao and Caroline Wright
    Citation: Radiation Oncology 2024 19:123
  39. Tumor-immune interactions shape a developing tumor and its tumor immune microenvironment (TIME) resulting in either well-infiltrated, immunologically inflamed tumor beds, or immune deserts with low levels of i...

    Authors: Rebecca A. Bekker, Nina Obertopp, Gage Redler, José Penagaricano, Jimmy J. Caudell, Kosj Yamoah, Shari Pilon-Thomas, Eduardo G. Moros and Heiko Enderling
    Citation: Radiation Oncology 2024 19:121
  40. To explore the high-risk factors affecting the prognosis of pT1 − 2N1M0 patients after mastectomy, establish a nomogram prediction model, and screen the radiotherapy benefit population.

    Authors: Chao Wei, Jie Kong, Huina Han, Xue Wang, Zimeng Gao, Danyang Wang, Andu Zhang, Jun Zhang and Zhikun Liu
    Citation: Radiation Oncology 2024 19:120

    The Correction to this article has been published in Radiation Oncology 2025 20:11

  41. Glioblastoma (GBM), the most common primary brain malignancy in adults, is notoriously difficult to treat due to several factors: tendency to be radiation resistant, the presence of the blood brain barrier (BB...

    Authors: Xin Wen, Zhiying Shao, Xueting Chen, Hongmei Liu, Hui Qiu, Xin Ding, Debao Qu, Hui Wang, Andrew Z. Wang and Longzhen Zhang
    Citation: Radiation Oncology 2024 19:119
  42. In locally advanced rectal cancer (LARC), optimizing neoadjuvant strategies, including the addition of concurrent chemotherapy and dose escalation of radiotherapy, is essential to improve tumor regression and ...

    Authors: Haohua Wang, Xiang Zhang, Boyu Leng, Kunli Zhu, Shumei Jiang, Rui Feng, Xue Dou, Fang Shi, Lei Xu and Jinbo Yue
    Citation: Radiation Oncology 2024 19:118
  43. The interaction between breathing motion and scanning beams causes interplay effects in spot-scanning proton therapy for lung cancer, resulting in compromised treatment quality. This study investigated the eff...

    Authors: Akihiro Yamano, Tatsuya Inoue, Takayuki Yagihashi, Masashi Yamanaka, Kazuki Matsumoto, Takahiro Shimo, Ryosuke Shirata, Kazunori Nitta, Hironori Nagata, Sachika Shiraishi, Yumiko Minagawa, Motoko Omura, Koichi Tokuuye and Weishan Chang
    Citation: Radiation Oncology 2024 19:117
  44. A predictive assay for late radiation toxicity would allow more personalized treatment planning, reducing the burden of toxicity for the more sensitive minority, and improving the therapeutic index for the maj...

    Authors: Anna C. Nuijens, Arlene L. Oei, Lisa Koster, Ron A. Hoebe, Nicolaas A.P. Franken, Coen R.N. Rasch and Lukas J.A. Stalpers
    Citation: Radiation Oncology 2024 19:116
  45. Magnetic resonance-guided adaptive radiotherapy (MRgART) at MR-Linac allows for plan optimisation on the MR-based synthetic CT (sCT) images, adjusting the target and organs at risk according to the patient’s d...

    Authors: Xin Xin, Bin Tang, Fan Wu, Jinyi Lang, Jie Li, Xianliang Wang, Min Liu, Qingxian Zhang, Xiongfei Liao, Feng Yang and Lucia Clara Orlandini
    Citation: Radiation Oncology 2024 19:114
  46. To identify variables associated with a patients’ ability to reproducibly hold their breath for deep-inspiration breath-hold (DIBH) radiotherapy (RT) and to develop a predictive model for DIBH eligibility.

    Authors: Irfan Ahmad, Kundan Singh Chufal, Alexis Andrew Miller, Ram Bajpai, Preetha Umesh, Balamrit Singh Sokhal, Kratika Bhatia, Shilpa Pati and Munish Gairola
    Citation: Radiation Oncology 2024 19:115
  47. Currently, there are few prospective data on the tolerability of combining targeted therapies (TT) with radiation therapy (RT). The objective of this prospective study was to assess the feasibility and toxicit...

    Authors: Dinah Konnerth, Aurelie Gaasch, C. Benedikt Westphalen, Kathrin Heinrich, Maximilian Niyazi, Chukwuka Eze, Paul Rogowski, Sebastian Marschner, Annemarie Zinn, Claus Belka, Stefanie Corradini and Stephan Schönecker
    Citation: Radiation Oncology 2024 19:113

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2024
    Submission to first editorial decision (median days): 16
    Submission to acceptance (median days): 135

    Usage 2024
    Downloads: 2,096,424
    Altmetric mentions: 233